- Home
- GHM vs ZVRA Comparison
GHM vs ZVRA Comparison
Compare GHM & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHM
- ZVRA
- Stock Information
- Founded
- GHM 1936
- ZVRA 2006
- Country
- GHM United States
- ZVRA United States
- Employees
- GHM N/A
- ZVRA N/A
- Industry
- GHM Industrial Machinery/Components
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- GHM Industrials
- ZVRA Health Care
- Exchange
- GHM Nasdaq
- ZVRA Nasdaq
- Market Cap
- GHM 480.7M
- ZVRA 458.5M
- IPO Year
- GHM N/A
- ZVRA 2015
- Fundamental
- Price
- GHM $46.66
- ZVRA $8.15
- Analyst Decision
- GHM Buy
- ZVRA Strong Buy
- Analyst Count
- GHM 1
- ZVRA 7
- Target Price
- GHM $35.00
- ZVRA $21.20
- AVG Volume (30 Days)
- GHM 88.3K
- ZVRA 492.6K
- Earning Date
- GHM 02-03-2025
- ZVRA 11-12-2024
- Dividend Yield
- GHM N/A
- ZVRA N/A
- EPS Growth
- GHM 172.71
- ZVRA N/A
- EPS
- GHM 0.71
- ZVRA N/A
- Revenue
- GHM $196,402,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- GHM $13.21
- ZVRA N/A
- Revenue Next Year
- GHM $9.89
- ZVRA $384.62
- P/E Ratio
- GHM $65.50
- ZVRA N/A
- Revenue Growth
- GHM 11.88
- ZVRA 47.85
- 52 Week Low
- GHM $18.90
- ZVRA $4.20
- 52 Week High
- GHM $49.28
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- GHM 61.24
- ZVRA 45.71
- Support Level
- GHM $40.50
- ZVRA $7.61
- Resistance Level
- GHM $49.28
- ZVRA $8.10
- Average True Range (ATR)
- GHM 2.06
- ZVRA 0.37
- MACD
- GHM 0.05
- ZVRA -0.02
- Stochastic Oscillator
- GHM 70.16
- ZVRA 40.30
About GHM Graham Corporation
Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.